Correlation of the Single-Assessment Numeric Evaluation (SANE) Score With Hip-Specific Patient-Reported Outcome Measures

Abstract

The purpose of this study was to determine if the Single-Assessment Numeric Evaluation (SANE) score correlates with existing validated hip-specific patient-reported outcome measures (PROMs), including the Modified Harris Hip Score (mHHS), the International Hip Outcome Tool (IHOT-33), the Hip Outcome Score, Activities of Daily Living subscale (HOS-ADL), and the Hip Outcome Score, Sport-Specific subscale (HOS-SS), for patients preparing to undergo hip arthroscopy for treatment of femoroacetabular impingement syndrome (FAIS). Methods: A single surgeon's operative database was retrospectively reviewed to identify patients undergoing primary hip arthroscopy for treatment of FAIS from April 2018 to October 2019. Patient-specific factors including age, sex, body mass index (BMI), and duration of symptoms were collected. Preoperative SANE, mHHS, IHOT-33, HOS-ADL, and HOS-SS scores were analyzed. Statistical analysis using Pearson correlation was performed to identify the relationship between the SANE score and the mHHS, IHOT-33, HOS-ADL, and HOS-SS, preoperatively. Results: 154 patients were included in the study. The mean mHHS was 54.4 AE 11.7; mean IHOT-33 score was 32.7 AE 15.0; mean HOS-SS 42.9 AE 23.7; and mean HOS-ADL was 63.3 AE 1. The mean SANE score was 36.7 AE 19.9. The Simple Hip Score was directly correlated with the mHHS (P < .01), the IHOT-33 (P < .01); the HOS-ADL (P < .01), and the HOS-SS (P < .01). The mean patient age was 35.9 years; 109 (70.8%) were female and 45 (29.2%) were male. Average patient BMI was 26.9. At the time of patient completion of the questionnaire, the majority of patients (65%) had been having symptoms for >1 year. Conclusion: The SANE score was strongly correlated with mHHS, IHOT-33, HOS-ADL, and HOS-SS in the preoperative setting for patients undergoing hip arthroscopy for treatment of FAIS. Given its simplicity, SANE may be a valuable tool for rapid assessment of joint function and pain in this patient population. Level of Evidence: IV, therapeutic case series.

Accelerated versus Standard Rehabilitation after Meniscus Allograft Transplantation in the Knee

“…Demographic and operative data including age, sex, body mass index (BMI), and tobacco use were collected from the EMR. Patient reported outcome measures (PROMs), including Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function 31 , International Knee Documentation Committee (IKDC) form 32 , Single Assessment Numeric Evaluation (SANE) 33 , and visual analog scale for pain 34 were collected at each time point. All reported complications and re-operations were recorded in the EMR.…”

Platelet-rich plasma treatment for large joint osteoarthritis : Retrospective study highlighting a possible treatment protocol with long-lasting stimulation of the joint with an adequate dose of platelets

“…Clinical response was evaluated with a visual analog scale (VAS; 0 = no pain 10 = maximal pain) and a single-assessment numeric evaluation (SANE; 0 = fully dysfunctional 100 = normal function) [21] for joint pain and function, respectively. The following baseline characteristics potentially in uence the outcomes we measured: age, sex, joint involved, rheumatologic disease, tobacco use, diabetes status, sports intensity and competition level.…”

“…The clinical response was assessed using the visual analog scale (VAS) for pain (ranging from 0, indicating no pain, to 10, denoting maximal pain) and the single assessment numeric evaluation (SANE) score [21] for joint function (ranging from 0, indicating full dysfunction, to 100, indicating normal function). Various baseline characteristics that could impact outcomes were measured, including age, sex, affected joint, rheumatologic conditions, tobacco use, diabetes status, sports intensity, and competition level.…”

Effectiveness of Stromal Vascular Fraction (SVF) and Platelets Rich Plasma (PRP) in patients with Osteoarthritis: Study protocol for a phase III, prospective, randomized, controlled multi-center study: (SPOST study). (Preprint)

“…The secondary outcomes will be clinical parameters gathered at 6 months and 12 months follow-up: • Return to work and to sports in days. Assessment of the improvement of the affected cartilage quality using MRI and in the case of knee osteoarthritis the AMADEUS (Area Measurement And Depth & Underlying Structures) score [22] at 6 months and 12 months follow-up (previous MRI should not be dated more than 3 months before the intervention). These parameters will be measured at every study site visit.…”